

* GSK partner Hansoh reports first late-stage data for experimental lung cancer drug


(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...


(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...


(ShareCast News) - UK housebuilding shares have fallen 25% since Britain voted to leave the European Union and the sector has priced in a 5% drop in h...


(ShareCast News) - Hikma Pharmaceuticals' promotion to the FTSE 100 index was confirmed after the latest quarterly review was announced overnight, whi...